Portuguese biotechnology company Immunethep is receiving $2 million from CARB-X to develop a conjugate peptide-based vaccine ...
A study of primary care patients in 5 European countries found the mean antibiotic course duration for common respiratory ...
Rutgers Health experts discuss the infectious disease and the university's role in research and treatment Tuberculosis (TB) ...
Working towards more effective tuberculosis (TB) vaccinations, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with ...
Mumbai: Close to a crore people were screened for tuberculosis (TB) in the last 80 days across Maharashtra, and around 30,000 ...
Deputy chief public health officer Dr. Ekua Agyemang said the Department of Health is taking this opportunity to screen the whole community for tuberculosis (TB) with a ‘stepwise’ (one step at a time) ...
In an interview with THE WEEK Dr Swapnil M. Khadake, HOD & Consultant Critical Care, Fortis Hiranandani Hospital talks about ...
Dehradun: A recent report by the Comptroller and Auditor General (CAG) of India, presented during the Uttarakhand assembly ...
Innovative research at Weill Cornell Medicine introduces engineered mycobacteria strains with 'kill switches' for safer TB ...
Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill switches" that can be triggered to stop the ...